NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Swan Neck Bio

Swan Neck Bio

Private
CopenhagenHealthcare & Life Scienceshttps://www.swanneck.bio/

Last Round

Seed

Oct 1, 2025

Total Funding Raised

$3.97M

Company Overview

Swan Neck Bio is a biotechnology company that provides services and proprietary bioreactor technology to help food and biotech companies scale and commercialize microorganisms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

fermentation servicesstarter culturefermentation as a serviceinoculumbiomanufacturingmicroorganism scalingprecision fermentationbioprocess developmentfermentation CDMOCDMOsingle-use bioreactorfood techstrain bankingmetabolic pathway mapping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Swan Neck Bio Comps

Public and private peers based on sector, stage, and business model.

Swan Neck Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Swan Neck Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 1, 2025

Swan Neck Bio Investors

Notable investors and investment history

Swan Neck Bio investors
InvestorRounds
Future5Seed
Angular VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Grew 33% QoQ from 9 to 12 employees.

  • Jan 10, 2025

    Grew 80% QoQ, from 5 to 9 employees.

Swan Neck Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Swan Neck Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Swan Neck Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range12
Year Founded2023
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.